Pharmaceuticals 2012, 5(9), 925-943; doi:10.3390/ph5090925
Article

Differential Cellular and Molecular Effects of Butyrate and Trichostatin A on Vascular Smooth Muscle Cells

1email, 1email, 2email and 1,* email
Received: 21 July 2012; in revised form: 22 August 2012 / Accepted: 23 August 2012 / Published: 4 September 2012
(This article belongs to the Special Issue Epigenetic Therapies and Biomarkers)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The histone deacetylase (HDAC) inhibitors, butyrate and trichostatin A (TSA), are epigenetic histone modifiers and proliferation inhibitors by downregulating cyclin D1, a positive cell cycle regulator, and upregulating p21Cip1 and INK family of proteins, negative cell cycle regulators. Our recent study indicated cyclin D1 upregulation in vascular smooth muscle cells (VSMC) that are proliferation-arrested by butyrate. Here we investigate whether cyclin D1 upregulation is a unique response of VSMC to butyrate or a general response to HDAC inhibitors (HDACi) by evaluating the effects of butyrate and TSA on VSMC. While butyrate and TSA inhibit VSMC proliferation via cytostatic and cytotoxic effects, respectively, they downregulate cdk4, cdk6, and cdk2, and upregulate cyclin D3, p21Cip1 and p15INK4B, and cause similar effects on key histone H3 posttranslational modifications. Conversely, cyclin D1 is upregulated by butyrate and inhibited by TSA. Assessment of glycogen synthase 3-dependent phosphorylation, subcellular localization and transcription of cyclin D1 indicates that differential effects of butyrate and TSA on cyclin D1 levels are linked to disparity in cyclin D1 gene expression. Disparity in butyrate- and TSA-induced cyclin D1 may influence transcriptional regulation of genes that are associated with changes in cellular morphology/cellular effects that these HDACi confer on VSMC, as a transcriptional modulator.
Keywords: butyrate; trichostatin A; vascular smooth muscle cells; proliferation; cyclin D1; HDAC
PDF Full-text Download PDF Full-Text [1142 KB, uploaded 4 September 2012 15:32 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Milton, S.G.; Mathew, O.P.; Yatsu, F.M.; Ranganna, K. Differential Cellular and Molecular Effects of Butyrate and Trichostatin A on Vascular Smooth Muscle Cells. Pharmaceuticals 2012, 5, 925-943.

AMA Style

Milton SG, Mathew OP, Yatsu FM, Ranganna K. Differential Cellular and Molecular Effects of Butyrate and Trichostatin A on Vascular Smooth Muscle Cells. Pharmaceuticals. 2012; 5(9):925-943.

Chicago/Turabian Style

Milton, Shirlette G.; Mathew, Omana P.; Yatsu, Frank M.; Ranganna, Kasturi. 2012. "Differential Cellular and Molecular Effects of Butyrate and Trichostatin A on Vascular Smooth Muscle Cells." Pharmaceuticals 5, no. 9: 925-943.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert